Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine.

× No keyword cloud information.

5 in total

1. Pseudomyxoma peritonei: An uncommon tumor.

Authors: Surabhi Gupta; Garima Singh; Anurag Gupta; Hari Singh; A K Arya; Deepak Shrotriya; Anuj Kumar
Journal: Indian J Med Paediatr Oncol Date: 2010-04

2. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.

Authors: Filippo Pietrantonio; Rosa Berenato; Claudia Maggi; Marta Caporale; Massimo Milione; Federica Perrone; Elena Tamborini; Dario Baratti; Shigeki Kusamura; Luigi Mariani; Monica Niger; Alessia Mennitto; Annunziata Gloghini; Ilaria Bossi; Giulio Settanni; Adele Busico; Pietro Francesco Bagnoli; Maria Di Bartolomeo; Marcello Deraco; Filippo de Braud
Journal: J Transl Med Date: 2016-05-06 Impact factor: 5.531

3. Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models.

Authors: Karianne Giller Fleten; Christin Lund-Andersen; Stein Waagene; Torveig Weum Abrahamsen; Yrr Mørch; Kjetil Boye; Annette Torgunrud; Kjersti Flatmark
Journal: Transl Oncol Date: 2020-05-21 Impact factor: 4.243

4. A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab.

Authors: Erin D Powell; D Blair Macdonald; Akram M Elkeilani; Timothy R Asmis
Journal: Case Rep Oncol Date: 2009-07-17

5. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

Authors: A L Farquharson; N Pranesh; G Witham; R Swindell; M B Taylor; A G Renehan; S Rout; M S Wilson; S T O'Dwyer; M P Saunders
Journal: Br J Cancer Date: 2008-08-19 Impact factor: 7.640

5 in total